Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in
Market


Income Statement

You can view the Income Statement for the last 5 years.



INCOME STATEMENT

Mankind Pharma Ltd.

GO
Market Cap. ( ₹ in Cr. ) 102963.88 P/BV 6.10 Book Value ( ₹ ) 408.44
52 Week High/Low ( ₹ ) 2642/1910 FV/ML 1/1 P/E(X) 53.83
Book Closure 08/08/2025 EPS ( ₹ ) 46.31 Div Yield (%) 0.04
(₹ in Crs.)

ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
      
INCOME     
Revenue From Operations [Net]14277.6412207.4410333.638742.857781.56
Other Operating Revenues0.000.001.156.580.00
Total Operating Revenues14277.6412207.4410334.778749.437781.56
      
Other Income358.79536.79280.86128.57196.03
Total Revenue14636.4312744.2310615.638878.007977.58
      
EXPENSES     
Cost Of Materials Consumed2288.032016.351853.521813.662057.56
Purchase Of Stock-In Trade1727.971655.691409.85809.24813.75
Changes In Inventories Of FG,WIP And Stock-In Trade36.12-183.00-53.67290.74-449.59
Employee Benefit Expenses3183.902692.372274.731918.471620.59
Finance Costs639.28429.4133.5344.4758.61
Depreciation And Amortisation Expenses886.18621.22398.25325.92166.62
Other Expenses3424.213008.102315.282016.681749.88
Total Expenses12185.6910240.148231.497219.186017.43
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax2450.742504.092384.141658.811960.15
      
Exceptional Items-129.750.000.000.000.00
Profit/Loss Before Tax2320.992504.092384.141658.811960.15
      
Tax Expenses-Continued Operations     
Current Tax582.89596.04492.58327.56469.03
Deferred Tax-188.31-86.30-35.0034.0152.61
Total Tax Expenses394.58509.74457.59361.56521.64
Profit/Loss After Tax And Before ExtraOrdinary Items1926.411994.351926.561297.251438.51
      
Profit/Loss From Continuing Operations1926.411994.351926.561297.251438.51
      
Profit/Loss From Discontinuing Operations0.008.450.000.000.00
Total Tax Expenses Discontinuing Operations0.003.920.000.000.00
Net Profit/Loss From Discontinuing Operations0.004.530.000.000.00
Profit/Loss For The Period1926.411998.881926.561297.251438.51
      
Minority Interest-25.17-20.16-28.88-27.82-19.48
Share Of Profit/Loss Of Associates11.6912.2415.2112.4214.45
Consolidated Profit/Loss After MI And Associates1912.931990.961912.901281.861433.48
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)46.3549.2847.7532.0035.78
Diluted EPS (Rs.)46.5349.2047.6832.0035.78
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend41.270.000.000.000.00
ParticularsMar 26
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
INCOME 
Revenue From Operations [Net]14277.64
Other Operating Revenues0.00
Total Operating Revenues14277.64
Other Income358.79
Total Revenue14636.43
EXPENSES 
Cost Of Materials Consumed2288.03
Purchase Of Stock-In Trade1727.97
Changes In Inventories Of FG,WIP And Stock-In Trade36.12
Employee Benefit Expenses3183.90
Finance Costs639.28
Depreciation And Amortisation Expenses886.18
Other Expenses3424.21
Total Expenses12185.69
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax2450.74
Exceptional Items-129.75
Profit/Loss Before Tax2320.99
Tax Expenses-Continued Operations 
Current Tax582.89
Deferred Tax-188.31
Total Tax Expenses394.58
Profit/Loss After Tax And Before ExtraOrdinary Items1926.41
Profit/Loss From Continuing Operations1926.41
Profit/Loss From Discontinuing Operations0.00
Total Tax Expenses Discontinuing Operations0.00
Net Profit/Loss From Discontinuing Operations0.00
Profit/Loss For The Period1926.41
Minority Interest-25.17
Share Of Profit/Loss Of Associates11.69
Consolidated Profit/Loss After MI And Associates1912.93
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)46.35
Diluted EPS (Rs.)46.53
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend41.27